Skip to main content
All lobbying filings

INVARIANT LLC

Lobbying for GLYTEC, LLC · Insulin management software

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 19, 2026

Official filing document

 Lobbying activity 1
Health Issues

Educate policymakers on the importance of effective glycemic management practices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem